Loading...
Cefpodoxime — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Cefpodoxime
2025-Q4
Comprehensive analysis of India’s cefpodoxime export trade — suppliers, buyers, prices, routes, and every shipment record.
99
Shipments
$1.68M
Trade Value
35
Suppliers
36
Buyers
20
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/cefpodoxime
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s cefpodoxime trade — 2025-Q4
KEY TAKEAWAY
Cefpodoxime 2025-Q4 exports total $1.7M across 20 countries, with LUPIN LTD commanding 53.2% market share.
TOTAL SHIPMENTS
99
2025-Q4
EXPORT VALUE
$1.7M
FOB USD
TOTAL QUANTITY
2.6M
units shipped
INDIAN SUPPLIERS
35
unique exporters
GLOBAL BUYERS
36
unique importers
DESTINATIONS
20
countries
MEDIAN UNIT PRICE
$1.64
per unit
TOP-5 SHARE
81.7%
of total USD
BRANDED SHARE
81.8%
81 shipments
DOSAGE FORMS
8
product types
6 KEY FINDINGS
1
LUPIN LTD is India's #1 Cefpodoxime exporter with $892.9K (53.2% market share).→ §5, Indian Supplier Rankings
2
Cefpodoxime reached 20 countries, with Greece as the top destination ($830.0K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 3084) — top 10 suppliers control 95.3% of exports.→ §5, Indian Supplier Rankings
4
88.9% of buyers (32 of 36) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (80.9%) across 8 dosage forms.→ §7, Price Benchmarks
6
20 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 LUPIN LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian cefpodoxime exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Cefpodoxime report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial cefpodoxime trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian cefpodoxime suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Cefpodoxime India trade report
Product scope
Cefpodoxime
All variants merged — branded and generic formulations of cefpodoxime
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
99
Every commercial cefpodoxime trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $283.3K, Nov $1.1M, Dec $255.2K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$283.3K
Oct USD
15 shipments
2
$1.1M
Nov USD
+302.7% MoM
3
$255.2K
Dec USD
-77.6% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 302.7% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $283K, making it the middle month by value.
Fig 3.2 Q4 cumulative USD reached $1.7M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $858K rise in Nov, $886K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $283K | 15 shipments |
| Nov | $1.1M | 43 shipments |
| Dec | $255K | 41 shipments |
| Q4 Total | $1.7M | 99 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: United States held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: SAKAR HEALTHCARE LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import cefpodoxime from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Greece absorbs 49.4% of India’s 2025-Q4 cefpodoxime trade ($830.0K). Beyond the top 10 destinations, 20 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 8 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 20 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much cefpodoxime India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$74K
4.4% of trade
6 countries · 22 shipments
Europe
$906K
54.0% of trade
3 countries · 21 shipments
Americas
$300K
17.9% of trade
2 countries · 10 shipments
Africa
$399K
23.7% of trade
8 countries · 43 shipments
Oceania
$45
0.0% of trade
1 countries · 3 shipments
Fig 4.1 Greece is the #1 corridor ($830K) — 20 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian cefpodoxime it receives (light = low, dark = high). Orange arcs radiate from India to the top 20 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Greece | $830K | 15 | LUPIN LTD | $830K | — | — | — | — |
| 2 | United States | $300K | 8 | ALKEM LABORATORIES LTD | $124K | FDC LTD | $97K | AUROBINDO PHARMA LTD | $79K |
| 3 | Nigeria | $132K | 5 | TWENTYFIRST CENTURY PHARMACEUTICALS PRIVATE LIMITE | $108K | BHARAT PARENTERALS LTD | $25K | — | — |
| 4 | South Africa | $107K | 4 | AUROBINDO PHARMA LTD | $65K | LUPIN LTD | $34K | ALKEM LABORATORIES LTD | $7K |
| 5 | Sudan | $96K | 10 | INNOVA CAPTAB LTD | $81K | SANCE LABORATORIES PVT LTD | $9K | MILTON GLOBEXO LLP | $5K |
| 6 | Vietnam | $56K | 6 | UNOSOURCE PHARMA LTD | $49K | MAXIM PHARMACEUTICALS PVT LTD | $8K | — | — |
| 7 | France | $48K | 5 | AJANTA PHARMA LTD | $32K | SAKAR HEALTHCARE LTD | $16K | GLOBAL PHARMA HEALTHCARE PVT LTD | $118 |
| 8 | Kenya | $30K | 15 | AQUAREN HEALTHCARE PVT LTD | $10K | ZEST PHARMA | $8K | KLV HEALTHCARE PVT LTD | $6K |
| 9 | Germany | $28K | 1 | LUPIN LTD | $28K | — | — | — | — |
| 10 | DR Congo | $20K | 2 | SAKAR HEALTHCARE LTD | $17K | AURA PHARMACEUTICALS PVT LTD | $4K | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 4.4% of USD — but Greece is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
49.4%
#1 country share
Greece alone
87.3%
Top 5 share
5 of 20 countries
100.0%
Top 15 share
Long tail of 5 countries = 0.0%
HHI 2924
Destination HHI
Highly concentrated
20
Countries served
Global pharma reach from India
8
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
35 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
LUPIN LTD ($892.9K, 53.2% share) and AUROBINDO PHARMA LTD ($144.3K) together control 61.8% of India’s 2025-Q4 cefpodoxime trade. The top 5 suppliers hold 81.7%. 35 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian cefpodoxime suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 LUPIN LTD leads by $749K over AUROBINDO PHARMA LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: KLV HEALTHCARE PVT is #17 by value but #2 by volume.
Fig 5.2 LUPIN LTD also leads by shipment count (17) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: KLV HEALTHCARE PVT moves from #2 by volume to #17 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 35 cefpodoxime suppliers split into strategic segments
KEY TAKEAWAY
9 suppliers (25%) generate 93.8% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 LUPIN LTD and AUROBINDO PHARMA LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 93.8% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | LUPIN LTD | 4 | 3 | $893K |
| 2 | AUROBINDO PHARMA LTD | 2 | 2 | $144K |
| 3 | INNOVA CAPTAB LTD | 2 | 2 | $90K |
| 4 | AJANTA PHARMA LTD | 2 | 1 | $32K |
| 5 | ZEST PHARMA | 2 | 1 | $8K |
| 6 | ALKEM LABORATORIES LTD | 1 | 2 | $132K |
| 7 | TWENTYFIRST CENTURY PHARMACEUTICALS PRIVATE LIMITE | 1 | 1 | $108K |
| 8 | FDC LTD | 1 | 1 | $97K |
| 9 | UNOSOURCE PHARMA LTD | 1 | 1 | $49K |
| 10 | SAKAR HEALTHCARE LTD | 1 | 2 | $33K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the cefpodoxime manufacturing hubs
KEY TAKEAWAY
Mumbai and Patancheru (M) together account for $1.2M of India’s 2025-Q4 cefpodoxime trade.
Fig 5.5 Mumbai (9 exporters, $1.1M) and Patancheru (M) (1 exporters, $144K) are India’s cefpodoxime capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
81.7%
Top 5 share
5 of 35 suppliers
95.3%
Top 10 share
10 of 35 suppliers
93.8%
Top 25% share
9 suppliers = 94% USD
HHI 3084
Supplier HHI
Concentrated
35
Total suppliers
shipped Cefpodoxime in 2025-Q4
20+ cities
Indian hubs
Mumbai and Patancheru (M) lead
§5.2 Coming next: 2 exporter deep-dive profiles
Each of the top 2 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | LUPIN LTD | $893K |
| #2 | INNOVA CAPTAB LTD | $90K |
#1
2025-Q4 USD
$893K
53.2% market share
SHIPMENTS
17
avg $53K/ship
COUNTRIES
3
destination markets
BUYERS
3
3 single-sourced
BRANDED
94%
of shipments
DOSAGE FORMS
4
product types
TOP 3 DESTINATIONS
Greece is the #1 market at $830K (93% of trade), followed by South Africa at $34K. 3 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Greece | $830K | 15 | 93.0% |
| 2 | South Africa | $34K | 1 | 3.9% |
| 3 | Germany | $28K | 1 | 3.2% |
MONTHLY TREND
Nov peaked at $830K. Dec was the weakest at $0.
PRODUCT MIX
Tablet dominates at 76% of trade. Solution (11.2%) and Suspension are secondary formulations.
TOP BUYERS · 3/3 LOCKED IN
3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| ALKALOID AD SKOPJE | Greece | $830K | ⚠ Locked |
| UPD LEA GLEN, PHARMA D… | South Africa | $34K | ⚠ Locked |
| MERCKLE GMBHMERCKLE GMBH | Germany | $28K | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 2 — TRADE FLOW MAP
LUPIN LTD — Supplier → Country → Importer
3 destination countries, top 5 importers per country
Fig 5.P1.3 Greece absorbs $830K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.
#6
2025-Q4 USD
$90K
5.3% market share
SHIPMENTS
6
avg $15K/ship
COUNTRIES
2
destination markets
BUYERS
2
1 single-sourced
BRANDED
100%
of shipments
DOSAGE FORMS
2
product types
TOP 2 DESTINATIONS
Sudan is the #1 market at $81K (90% of trade), followed by Tanzania at $9K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Sudan | $81K | 4 | 90.4% |
| 2 | Tanzania | $9K | 2 | 9.6% |
MONTHLY TREND
Nov peaked at $90K. Oct was the weakest at $0.
PRODUCT MIX
Tablet dominates at 97% of trade. Suspension (3.0%) and others are secondary formulations.
TOP BUYERS · 1/2 LOCKED IN
1 of 2 buyers source exclusively from this supplier — moderate lock-in, some buyers diversify.
| Buyer | Country | USD | Status |
|---|---|---|---|
| ELWALIEF INTERNATIONAL… | Sudan | $81K | ⚠ Locked |
| STE PRINCE PHARMA SARL | Tanzania | $9K | 2 sup. |
#6
EXPORTER PROFILE #2 OF 2 — TRADE FLOW MAP
INNOVA CAPTAB LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P2.3 Sudan absorbs $81K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
36 importers across 20 countries — who is buying Indian cefpodoxime and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 95.6% of total USD. 89% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian cefpodoxime. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 ALKALOID AD SKOPJE is the #1 importer at $830K (49.4%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
89%
Single-source
32 buyers rely on exactly 1 Indian supplier
8%
Dual-source
3 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
3%
Broad-source (5+)
1 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source cefpodoxime from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Sudan 4 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ELWALIEF INTERNATIONAL… | INNOVA CAPTAB LTD | $81K | $0.054 | Tablet |
| KADA FOR MULTI ACTIVIT… | SANCE LABORATORIES P… | $9K | $0.595 | Suspension |
| KUOL UTONG MIYEN | MILTON GLOBEXO LLP | $5K | $0.487 | Pack |
| QUEEENS ENTERPRISES CO… | BAKER & DAVIS PVT LTD | $2K | $0.420 | Tablet |
Kenya 4 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| EURO PHARMA LTD | AQUAREN HEALTHCARE P… | $10K | $2.870 | Dry Syrup |
| SYNER-MED PHARMACEUTIC… | ZEST PHARMA | $8K | $91.137 | Tablet |
| CYERDITTRADING CO LTD | AFRO LIFESCIENCE | $4K | $0.437 | Tablet |
| TRIDEM PHARMA KENYA LTD | ARISTO PHARMACEUTICA… | $1K | $2.210 | Dry Syrup |
United States 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ASCEND LABORATORIES LLC | ALKEM LABORATORIES LTD | $124K | $8.403 | Tablet |
| COVETRUS NORTH AMERICA… | FDC LTD | $97K | $5.781 | Tablet |
| CRONUS PHARMA LLC | AUROBINDO PHARMA LTD | $79K | $0.319 | Tablet |
South Africa 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| AUROGEN SOUTH AFRICA (… | AUROBINDO PHARMA LTD | $65K | $3.897 | Suspension |
| UPD LEA GLEN, PHARMA D… | LUPIN LTD | $34K | $2.101 | Suspension |
| ASCEND LABORATORIES (P… | ALKEM LABORATORIES LTD | $7K | $1.545 | Tablet |
Nigeria 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MARCSON HEALTHCARE LTD | TWENTYFIRST CENTURY … | $54K | $0.907 | Tablet |
| M/S.CHANRAIHEALTH CARE… | BHARAT PARENTERALS LTD | $25K | $0.992 | Tablet |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | ALKALOID AD SKOPJE | Greece | $830K | $55K | Premium |
| 2 | ASCEND LABORATORIES … | United States | $124K | $124K | Premium |
| 3 | COVETRUS NORTH AMERI… | United States | $97K | $16K | Mid |
| 4 | ELWALIEF INTERNATION… | Sudan | $81K | $20K | Mid |
| 5 | CRONUS PHARMA LLC | United States | $79K | $79K | Premium |
| 6 | AUROGEN SOUTH AFRICA… | South Africa | $65K | $32K | Mid |
| 7 | MARCSON HEALTHCARE LTD | Nigeria | $54K | $27K | Mid |
| 8 | ALLEGENS COMPANY LTD | Vietnam | $49K | $10K | Budget |
| 9 | PLANET PHARMA SA | France | $48K | $16K | Mid |
| 10 | UPD LEA GLEN, PHARMA… | South Africa | $34K | $34K | Mid |
| 11 | MERCKLE GMBHMERCKLE … | Germany | $28K | $28K | Mid |
| 12 | STE PRINCE PHARMA SARL | DR Congo | $25K | $8K | Budget |
| 13 | M/S.CHANRAIHEALTH CA… | Nigeria | $25K | $25K | Mid |
| 14 | EURO PHARMA LTD | Kenya | $10K | $5K | Budget |
| 15 | KADA FOR MULTI ACTIV… | Sudan | $9K | $9K | Budget |
| 16 | SYNER-MED PHARMACEUT… | Kenya | $8K | $4K | Budget |
| 17 | THAIAN MEDICAL IMPOR… | Vietnam | $8K | $8K | Budget |
| 18 | ASCEND LABORATORIES … | South Africa | $7K | $7K | Budget |
| 19 | TRUST ANESTHETIC LTD | Afghanistan | $6K | $3K | Budget |
| 20 | KUOL UTONG MIYEN | Sudan | $5K | $2K | Budget |
| 21 | CYERDITTRADING CO LTD | Kenya | $4K | $4K | Budget |
| 22 | TO,THE ORDER R.D. CO… | DR Congo | $4K | $4K | Budget |
| 23 | ADIL HISSEIN ISMAIL | Chad | $3K | $3K | Budget |
| 24 | AMDJERAS FIELD HOSPI… | Chad | $2K | $2K | Budget |
| 25 | QUEEENS ENTERPRISES … | Sudan | $2K | $529.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 LUPIN LTD → ALKALOID AD SKOPJE is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian cefpodoxime prices vary by supplier, country and dosage form
KEY TAKEAWAY
Cefpodoxime prices span 54417989× ($0.0000 → $260.31). The coefficient of variation is 5.06. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0000 | Lowest observed unit price |
| P5 | $0.028 | 5th percentile |
| P25 | $0.444 | 25th percentile (Q1) |
| Median | $1.64 | 50th percentile (Q2) |
| P75 | $3.02 | 75th percentile (Q3) |
| P95 | $8.73 | 95th percentile |
| Max | $260.31 | Highest observed unit price |
| Mean | $5.29 | Arithmetic average |
| CV | 506% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 ZEST PHARMA prices at $149.99/unit vs market median $1.64.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. TWENTYFIRST CENTURY PHARMACEUTICALS Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. LUPIN LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. BHARAT PARENTERALS LTD Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. AKASH PHARMA EXPORTS Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Oct 2025 | ZEST PHARMA | Kenya | Tablet | 22 | $6K | $260.31 | Specialty / small-batch |
| Oct 2025 | ZEST PHARMA | Kenya | Syrup | 71 | $3K | $39.67 | Specialty / small-batch |
| Nov 2025 | SANITAS MEDTECH … | Singapore | Tablet | 10 | $176.45 | $17.64 | Specialty / small-batch |
| Nov 2025 | FDC LTD | United States | Tablet | 3K | $44K | $14.92 | Specialty / small-batch |
| Nov 2025 | FDC LTD | United States | Tablet | 4K | $35K | $8.73 | Specialty / small-batch |
| Nov 2025 | FDC LTD | United States | Tablet | 2K | $17K | $8.73 | Specialty / small-batch |
| Dec 2025 | ALKEM LABORATORI… | United States | Tablet | 15K | $124K | $8.40 | Specialty / small-batch |
| Nov 2025 | LUPIN LTD | Greece | Tablet | 18K | $103K | $5.72 | Specialty / small-batch |
| Nov 2025 | LUPIN LTD | Greece | Tablet | 7K | $41K | $5.70 | Specialty / small-batch |
| Nov 2025 | LUPIN LTD | Greece | Tablet | 7K | $41K | $5.70 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | BRINTON PHARMACE… | Vanuatu | Tablet | 10 | $0.248 | $0.025 | Small sample / trial shipment |
| Dec 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 12 | $0.320 | $0.027 | Small sample / trial shipment |
| Dec 2025 | JPC GLOBAL | Hong Kong | Suspension | 6 | $0.171 | $0.028 | Small sample / trial shipment |
| Dec 2025 | JPC GLOBAL | Hong Kong | Suspension | 20 | $0.569 | $0.028 | Small sample / trial shipment |
| Dec 2025 | JPC GLOBAL | Hong Kong | Suspension | 174 | $4.95 | $0.028 | Small sample / trial shipment |
| Dec 2025 | RICHMEL LIFE SCI… | France | Dispersible Tablet | 750 | $26.85 | $0.036 | Small sample / trial shipment |
| Nov 2025 | INNOVA CAPTAB LTD | Sudan | Tablet | 383K | $21K | $0.054 | |
| Nov 2025 | INNOVA CAPTAB LTD | Sudan | Tablet | 384K | $21K | $0.054 | |
| Nov 2025 | INNOVA CAPTAB LTD | Sudan | Tablet | 337K | $18K | $0.054 | |
| Nov 2025 | INNOVA CAPTAB LTD | Sudan | Tablet | 392K | $21K | $0.054 |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship cefpodoxime, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Cefpodoxime leaves India through 12+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), DELHI AIR, HYDERABAD ICD) handle 97.0% of total USD. SEA moves 40% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $1.2M — top 12 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Thessaloniki is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 40% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$1.3M
74.7% of USD · 40.4% of ships
AIR
$228K
13.6% of USD · 47.5% of ships
ICD
$197K
11.7% of USD · 12.1% of ships
Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → Europe ($899K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Greece is the most concentrated destination (HHI 10000, 1 suppliers). Kenya is the most competitive (HHI 2514).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Greece (HHI 10,000) is the most concentrated — Kenya (HHI 2,514) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| ALKALOID AD SKOPJE | Greece | LUPIN LTD | $830K | 15 | CRITICAL |
| ASCEND LABORATORIES … | United States | ALKEM LABORATORI… | $124K | 1 | HIGH |
| COVETRUS NORTH AMERI… | United States | FDC LTD | $97K | 6 | MEDIUM |
| ELWALIEF INTERNATION… | Sudan | INNOVA CAPTAB LTD | $81K | 4 | MEDIUM |
| CRONUS PHARMA LLC | United States | AUROBINDO PHARMA… | $79K | 1 | MEDIUM |
| AUROGEN SOUTH AFRICA… | South Africa | AUROBINDO PHARMA… | $65K | 2 | MEDIUM |
| MARCSON HEALTHCARE LTD | Nigeria | TWENTYFIRST CENT… | $54K | 2 | MEDIUM |
| ALLEGENS COMPANY LTD | Vietnam | UNOSOURCE PHARMA… | $49K | 5 | MEDIUM |
Conclusion: 31 buyers depend on exactly one Indian supplier, representing $1.5M in trade. 1 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Greece | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| United States | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nigeria | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| South Africa | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Sudan | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Vietnam | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| France | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Germany | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| DR Congo | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Cambodia | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Tanzania | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Afghanistan | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Chad | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Somalia | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 11 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Greece | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Greece lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Greece (1 suppliers) | This Q | HIGH |
| A6 | Enter United States (3 suppliers) | This Q | MED |
| A8 | Build United States distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Greece tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Greece | Other | 1 | $830K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | United States | Other | 3 | $300K | +57.7% | LOW | Growing 58% with only 3 competitors |
| 3 | Nigeria | Africa | 2 | $132K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | South Africa | Africa | 3 | $107K | -100% | LOW | Low competition (3 suppliers), accessible market |
| 5 | Sudan | Africa | 4 | $96K | -45.4% | LOW | Low competition (4 suppliers), accessible market |
| 6 | Kenya | Africa | 5 | $30K | +136.3% | LOW | Growing 136% with only 5 competitors |
| 7 | Vietnam | Asia | 2 | $56K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | France | Other | 4 | $48K | 0% | LOW | Low competition (4 suppliers), accessible market |
| 9 | Germany | Other | 1 | $28K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | DR Congo | Africa | 2 | $20K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Cambodia | Asia | 1 | $12K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Tanzania | Africa | 1 | $9K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Chad | Africa | 2 | $4K | +51.9% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Afghanistan | Asia | 1 | $6K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Somalia | Africa | 3 | $478 | +989.6% | LOW | Growing 990% with only 3 competitors |
This report covers 99 2025-Q4 Cefpodoxime shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/cefpodoxime
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 99 2025-Q4 cefpodoxime shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian cefpodoxime shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
99
across all regions
TOTAL USD
$1.68M
2025-Q4 FOB value
UNITS
2.6M
tablets, capsules, etc.
SUPPLIERS
35
Indian exporters
BUYERS
36
global importers
COUNTRIES
20
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $399K (23.7%), spanning 8 countries.
35 Indian suppliers shipped to 36 buyers across 20 countries — average shipment value $17K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
8 countries · 43 shipments · $399K · 20 Indian suppliers · 21 buyers
SHIPMENTS
43
USD
$399K
COUNTRIES
8
SUPPLIERS
20
BUYERS
21
HHI
1,655
moderate
Top 8 destination countries in Africa
1
Nigeria (33.2%)
$132K
2
South Africa (26.8%)
$107K
3
Sudan (24.1%)
$96K
4
Kenya (7.5%)
$30K
5
DR Congo (5.1%)
$20K
6
Tanzania (2.1%)
$9K
7
Chad (1.0%)
$4K
8
Somalia (0.1%)
$477.96
Top 20 Indian suppliers into Africa
1
TWENTYFIRST CENTURY PHARMACEUTICALS PRIVATE LIMITE
$108K
2
INNOVA CAPTAB LTD
$90K
3
AUROBINDO PHARMA LTD
$65K
4
LUPIN LTD
$34K
5
BHARAT PARENTERALS LTD
$25K
6
SAKAR HEALTHCARE LTD
$17K
7
AQUAREN HEALTHCARE PVT LTD
$10K
8
SANCE LABORATORIES PVT LTD
$9K
9
ZEST PHARMA
$8K
10
ALKEM LABORATORIES LTD
$7K
11
KLV HEALTHCARE PVT LTD
$6K
12
MILTON GLOBEXO LLP
$5K
13
AFRO LIFESCIENCE
$4K
14
BAKER & DAVIS PVT LTD
$4K
15
AURA PHARMACEUTICALS PVT LTD
$4K
16
AKASH PHARMA EXPORTS
$2K
17
ARISTO PHARMACEUTICALS PVT LTD
$1K
18
TRAILBLAZERS PHARMACEUTICALS
$413.31
19
SAINTROY LIFESCIENCE LLP
$40.18
20
CURE EARTH PHARMA
$24.48
Top 19 Africa importers
1
ELWALIEF INTERNATIONAL FOR MULTI · Sudan
$81K
2
AUROGEN SOUTH AFRICA (PTY) LTD · South Africa
$65K
3
MARCSON HEALTHCARE LTD · Nigeria
$54K
4
UPD LEA GLEN, PHARMA DYNAMICS · South Africa
$34K
5
STE PRINCE PHARMA SARL · DR Congo
$25K
6
M/S.CHANRAIHEALTH CARE LTD · Nigeria
$25K
7
EURO PHARMA LTD · Kenya
$10K
8
KADA FOR MULTI ACTIVITIES CO.LTDELI · Sudan
$9K
9
SYNER-MED PHARMACEUTICALS (KENYA) L · Kenya
$8K
10
ASCEND LABORATORIES (PTY) LTD · South Africa
$7K
11
KUOL UTONG MIYEN · Sudan
$5K
12
CYERDITTRADING CO LTD · Kenya
$4K
13
TO,THE ORDER R.D. CONGO, THE · DR Congo
$4K
14
ADIL HISSEIN ISMAIL · Chad
$3K
15
AMDJERAS FIELD HOSPITAL · Chad
$2K
16
QUEEENS ENTERPRISES CO LTD · Sudan
$2K
17
TRIDEM PHARMA KENYA LTD · Kenya
$1K
18
AMRA PHARMACEUTICALS · Somalia
$413.31
19
KALKAAL HOSPITAL · Somalia
$24.48
Top 6 dosage forms
1
Tablet
$263K
2
Suspension
$111K
3
Dry Syrup
$11K
4
Pack
$5K
5
Syrup
$4K
6
Dispersible Tablet
$4K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 11 | $163K | $15K |
| Nov | 15 | $208K | $14K |
| Dec | 17 | $28K | $2K |
Shipment register · 43 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — TWENTYFIRST CENTURY PHARMACEUTICALS PRIVATE LIMITE · 4 shipments · $108K | |||||||||||
| 1 | Nov 2025 | MARCSON HEALTHCARE LTD | Nigeria | Tablet | 39.3K | NOS | $1.02 | $40K | DELHI AIR | LAGOS | AIR |
| 2 | Nov 2025 | MARCSON HEALTHCARE LTD | Nigeria | Tablet | 19.9K | NOS | $0.689 | $14K | DELHI AIR | LAGOS | AIR |
| 3 | Nov 2025 | UNKNOWN BUYER | Nigeria | Tablet | 39.3K | NOS | $1.02 | $40K | DELHI AIR | LAGOS | AIR |
| 4 | Nov 2025 | UNKNOWN BUYER | Nigeria | Tablet | 19.9K | NOS | $0.689 | $14K | DELHI AIR | LAGOS | AIR |
| SUPPLIER #2 — INNOVA CAPTAB LTD · 6 shipments · $90K | |||||||||||
| 5 | Nov 2025 | STE PRINCE PHARMA SARL | Tanzania | Suspension | 4.4K | NOS | $0.624 | $3K | NHAVA SHEVA SEA (JNPT) | Dar Es Salaam | SEA |
| 6 | Nov 2025 | STE PRINCE PHARMA SARL | Tanzania | Tablet | 5.0K | NOS | $1.16 | $6K | NHAVA SHEVA SEA (JNPT) | Dar Es Salaam | SEA |
| 7 | Nov 2025 | ELWALIEF INTERNATIONAL FOR MULTI | Sudan | Tablet | 336.6K | TBS | $0.054 | $18K | MUNDRA SEA | Port Sudan | SEA |
| 8 | Nov 2025 | ELWALIEF INTERNATIONAL FOR MULTI | Sudan | Tablet | 383.1K | TBS | $0.054 | $21K | MUNDRA SEA | Port Sudan | SEA |
| 9 | Nov 2025 | ELWALIEF INTERNATIONAL FOR MULTI | Sudan | Tablet | 391.6K | TBS | $0.054 | $21K | MUNDRA SEA | Port Sudan | SEA |
| 10 | Nov 2025 | ELWALIEF INTERNATIONAL FOR MULTI | Sudan | Tablet | 384.0K | TBS | $0.054 | $21K | MUNDRA SEA | Port Sudan | SEA |
| SUPPLIER #3 — AUROBINDO PHARMA LTD · 2 shipments · $65K | |||||||||||
| 11 | Oct 2025 | AUROGEN SOUTH AFRICA (PTY) LTD | South Africa | Suspension | 8.3K | NOS | $4.84 | $40K | HYDERABAD ICD | DURBAN | ICD |
| 12 | Oct 2025 | AUROGEN SOUTH AFRICA (PTY) LTD | South Africa | Suspension | 8.4K | NOS | $2.96 | $25K | HYDERABAD ICD | DURBAN | ICD |
| SUPPLIER #4 — LUPIN LTD · 1 shipments · $34K | |||||||||||
| 13 | Oct 2025 | UPD LEA GLEN, PHARMA DYNAMICS | South Africa | Suspension | 16.4K | NOS | $2.10 | $34K | NHAVA SHEVA SEA (JNPT) | Johannesburg | SEA |
| SUPPLIER #5 — BHARAT PARENTERALS LTD · 1 shipments · $25K | |||||||||||
| 14 | Oct 2025 | M/S.CHANRAIHEALTH CARE LTD | Nigeria | Tablet | 25.0K | NOS | $0.992 | $25K | NHAVA SHEVA SEA (JNPT) | Apapa | SEA |
| SUPPLIER #6 — SAKAR HEALTHCARE LTD · 1 shipments · $17K | |||||||||||
| 15 | Oct 2025 | STE PRINCE PHARMA SARL | DR Congo | Tablet | 20.1K | NOS | $0.832 | $17K | AHMEDABAD ICD | MATADI | ICD |
| SUPPLIER #7 — AQUAREN HEALTHCARE PVT LTD · 2 shipments · $10K | |||||||||||
| 16 | Dec 2025 | EURO PHARMA LTD | Kenya | Dry Syrup | 1.8K | KGS | $3.16 | $6K | AHMEDABAD ICD | MOMBASA | ICD |
| 17 | Dec 2025 | EURO PHARMA LTD | Kenya | Dry Syrup | 1.7K | KGS | $2.57 | $4K | AHMEDABAD ICD | MOMBASA | ICD |
| SUPPLIER #8 — SANCE LABORATORIES PVT LTD · 1 shipments · $9K | |||||||||||
| 18 | Oct 2025 | KADA FOR MULTI ACTIVITIES CO.LTDELI | Sudan | Suspension | 14.8K | NOS | $0.595 | $9K | NHAVA SHEVA SEA (JNPT) | Khartoum | SEA |
| SUPPLIER #9 — ZEST PHARMA · 2 shipments · $8K | |||||||||||
| 19 | Oct 2025 | SYNER-MED PHARMACEUTICALS (KENYA) L | Kenya | Tablet | 22 | KGS | $260.31 | $6K | PITHAMPUR ICD | MOMBASA | ICD |
| 20 | Oct 2025 | SYNER-MED PHARMACEUTICALS (KENYA) L | Kenya | Syrup | 71 | KGS | $39.67 | $3K | PITHAMPUR ICD | MOMBASA | ICD |
| SUPPLIER #10 — ALKEM LABORATORIES LTD · 1 shipments · $7K | |||||||||||
| 21 | Nov 2025 | ASCEND LABORATORIES (PTY) LTD | South Africa | Tablet | 4.8K | NOS | $1.54 | $7K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| SUPPLIER #11 — KLV HEALTHCARE PVT LTD · 9 shipments · $6K | |||||||||||
| 22 | Dec 2025 | UNLISTED BUYER | Kenya | Tablet | 70 | NOS | $1.64 | $114.80 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 23 | Dec 2025 | UNLISTED BUYER | Kenya | Tablet | 600 | NOS | $1.64 | $984.00 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 24 | Dec 2025 | UNLISTED BUYER | Kenya | Tablet | 260 | NOS | $1.64 | $426.40 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 25 | Dec 2025 | UNLISTED BUYER | Kenya | Tablet | 180 | NOS | $2.06 | $371.21 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 26 | Dec 2025 | UNLISTED BUYER | Kenya | Tablet | 660 | NOS | $2.06 | $1K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 27 | Dec 2025 | UNLISTED BUYER | Kenya | Tablet | 360 | NOS | $2.06 | $741.70 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 28 | Dec 2025 | UNLISTED BUYER | Kenya | Tablet | 100 | NOS | $1.67 | $167.27 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 29 | Dec 2025 | UNLISTED BUYER | Kenya | Tablet | 800 | NOS | $1.67 | $1K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| 30 | Dec 2025 | UNLISTED BUYER | Kenya | Tablet | 100 | NOS | $1.67 | $167.27 | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #12 — MILTON GLOBEXO LLP · 2 shipments · $5K | |||||||||||
| 31 | Dec 2025 | KUOL UTONG MIYEN | Sudan | Pack | 7.3K | NOS | $0.500 | $4K | MUMBAI AIR (SAHAR) | JUBA | AIR |
| 32 | Dec 2025 | KUOL UTONG MIYEN | Sudan | Pack | 2.6K | NOS | $0.450 | $1K | MUMBAI AIR (SAHAR) | JUBA | AIR |
| SUPPLIER #13 — AFRO LIFESCIENCE · 1 shipments · $4K | |||||||||||
| 33 | Dec 2025 | CYERDITTRADING CO LTD | Kenya | Tablet | 9.9K | PCS | $0.437 | $4K | NHAVA SHEVA SEA (JNPT) | Mombasa | SEA |
| SUPPLIER #14 — BAKER & DAVIS PVT LTD · 4 shipments · $4K | |||||||||||
| 34 | Nov 2025 | QUEEENS ENTERPRISES CO LTD | Sudan | Tablet | 1.5K | NOS | $0.339 | $509.13 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| 35 | Nov 2025 | QUEEENS ENTERPRISES CO LTD | Sudan | Tablet | 1.0K | NOS | $0.489 | $489.17 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| 36 | Nov 2025 | QUEEENS ENTERPRISES CO LTD | Sudan | Tablet | 1.3K | NOS | $0.459 | $587.80 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| 37 | Dec 2025 | ADIL HISSEIN ISMAIL | Chad | Tablet | 5.0K | NOS | $0.500 | $3K | MUMBAI AIR (SAHAR) | N'DJAMENA | AIR |
| SUPPLIER #15 — AURA PHARMACEUTICALS PVT LTD · 1 shipments · $4K | |||||||||||
| 38 | Oct 2025 | TO,THE ORDER R.D. CONGO, THE | DR Congo | Dispersible Tablet | 4.6K | NOS | $0.762 | $4K | NHAVA SHEVA SEA (JNPT) | Dar Es Salaam | SEA |
| SUPPLIER #16 — AKASH PHARMA EXPORTS · 1 shipments · $2K | |||||||||||
| 39 | Oct 2025 | AMDJERAS FIELD HOSPITAL | Chad | Syrup | 600 | NOS | $2.74 | $2K | COCHIN SEA | N'DJAMENA | AIR |
| SUPPLIER #17 — ARISTO PHARMACEUTICALS PVT LTD · 1 shipments · $1K | |||||||||||
| 40 | Nov 2025 | TRIDEM PHARMA KENYA LTD | Kenya | Dry Syrup | 633 | NOS | $2.21 | $1K | NHAVA SHEVA SEA (JNPT) | Mombasa | SEA |
| SUPPLIER #18 — TRAILBLAZERS PHARMACEUTICALS · 1 shipments · $413.31 | |||||||||||
| 41 | Dec 2025 | AMRA PHARMACEUTICALS | Somalia | Suspension | 900 | NOS | $0.459 | $413.31 | NHAVA SHEVA SEA (JNPT) | Berbera | SEA |
| SUPPLIER #19 — SAINTROY LIFESCIENCE LLP · 1 shipments · $40.18 | |||||||||||
| 42 | Oct 2025 | UNLISTED BUYER | Somalia | Suspension | 24 | PCS | $1.67 | $40.18 | AHMEDABAD AIR | MOGADISCHU | AIR |
| SUPPLIER #20 — CURE EARTH PHARMA · 1 shipments · $24.48 | |||||||||||
| 43 | Dec 2025 | KALKAAL HOSPITAL | Somalia | Suspension | 50 | NOS | $0.490 | $24.48 | CHENNAI AIR | MOGADISCHU | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
6 countries · 22 shipments · $74K · 9 Indian suppliers · 8 buyers
SHIPMENTS
22
USD
$74K
COUNTRIES
6
SUPPLIERS
9
BUYERS
8
HHI
4,704
concentrated
Top 6 destination countries in Asia
1
Vietnam (75.6%)
$56K
2
Cambodia (16.3%)
$12K
3
Afghanistan (7.7%)
$6K
4
Singapore (0.3%)
$251.93
5
United Arab Emirates (0.2%)
$114.47
6
Hong Kong (0.0%)
$5.69
Top 9 Indian suppliers into Asia
1
UNOSOURCE PHARMA LTD
$49K
2
THEON PHARMACEUTICALS LTD
$12K
3
MAXIM PHARMACEUTICALS PVT LTD
$8K
4
S PHARMA
$6K
5
SANITAS MEDTECH INSTITUTE PVT LTD
$251.93
6
DERRIC WOOD
$112.45
7
JPC GLOBAL
$5.69
8
FALCON TRANSGLOBAL
$2.02
9
IASO PHARMACEUTICALS PVT LTD
$0.0000
Top 7 Asia importers
1
ALLEGENS COMPANY LTD · Vietnam
$49K
2
THAIAN MEDICAL IMPORT -EXPORT JOINT · Vietnam
$8K
3
TRUST ANESTHETIC LTD · Afghanistan
$6K
4
SUCCESS INTER LINK PTE LTD · Singapore
$251.93
5
EMIRATES POST COMPANY · United Arab Emirates
$112.45
6
TO THE, IMPORTING DEPARTMENT · Hong Kong
$5.69
7
EMIRATES POST GROUP · United Arab Emirates
$2.02
Top 2 dosage forms
1
Tablet
$74K
2
Suspension
$5.69
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $12K | $6K |
| Nov | 6 | $290.60 | $48.43 |
| Dec | 14 | $62K | $4K |
Shipment register · 22 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — UNOSOURCE PHARMA LTD · 5 shipments · $49K | |||||||||||
| 1 | Dec 2025 | ALLEGENS COMPANY LTD | Vietnam | Tablet | 9.8K | NOS | $0.632 | $6K | NHAVA SHEVA SEA (JNPT) | Ho Chi Minh City | SEA |
| 2 | Dec 2025 | ALLEGENS COMPANY LTD | Vietnam | Tablet | 29.7K | NOS | $0.357 | $11K | NHAVA SHEVA SEA (JNPT) | Ho Chi Minh City | SEA |
| 3 | Dec 2025 | ALLEGENS COMPANY LTD | Vietnam | Tablet | 29.7K | NOS | $0.357 | $11K | NHAVA SHEVA SEA (JNPT) | Ho Chi Minh City | SEA |
| 4 | Dec 2025 | ALLEGENS COMPANY LTD | Vietnam | Tablet | 29.8K | NOS | $0.357 | $11K | NHAVA SHEVA SEA (JNPT) | Ho Chi Minh City | SEA |
| 5 | Dec 2025 | ALLEGENS COMPANY LTD | Vietnam | Tablet | 29.7K | NOS | $0.357 | $11K | NHAVA SHEVA SEA (JNPT) | Ho Chi Minh City | SEA |
| SUPPLIER #2 — THEON PHARMACEUTICALS LTD · 2 shipments · $12K | |||||||||||
| 6 | Oct 2025 | UNLISTED BUYER | Cambodia | Tablet | 90.0K | NOS | $0.134 | $12K | TUGHLAKABAD ICD | Sihanoukville (Kompo | ICD |
| 7 | Oct 2025 | UNLISTED BUYER | Cambodia | Tablet | 8.0K | NOS | $0.0000 | $0.038 | TUGHLAKABAD ICD | Sihanoukville (Kompo | ICD |
| SUPPLIER #3 — MAXIM PHARMACEUTICALS PVT LTD · 1 shipments · $8K | |||||||||||
| 8 | Dec 2025 | THAIAN MEDICAL IMPORT -EXPORT JOINT | Vietnam | Tablet | 19.5K | NOS | $0.387 | $8K | NHAVA SHEVA SEA (JNPT) | Haiphong | SEA |
| SUPPLIER #4 — S PHARMA · 2 shipments · $6K | |||||||||||
| 9 | Dec 2025 | TRUST ANESTHETIC LTD | Afghanistan | Tablet | 2.4K | NOS | $0.184 | $441.03 | TUGHLAKABAD ICD | Kandahar | ICD |
| 10 | Dec 2025 | TRUST ANESTHETIC LTD | Afghanistan | Tablet | 28.6K | NOS | $0.184 | $5K | TUGHLAKABAD ICD | Kandahar | ICD |
| SUPPLIER #5 — SANITAS MEDTECH INSTITUTE PVT LTD · 2 shipments · $251.93 | |||||||||||
| 11 | Nov 2025 | SUCCESS INTER LINK PTE LTD | Singapore | Tablet | 10 | NOS | $17.64 | $176.45 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| 12 | Dec 2025 | SUCCESS INTER LINK PTE LTD | Singapore | Tablet | 50 | NOS | $1.51 | $75.49 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #6 — DERRIC WOOD · 4 shipments · $112.45 | |||||||||||
| 13 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 36 | PCS | $2.42 | $87.16 | DELHI AIR | DUBAI | AIR |
| 14 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $2.78 | $24.98 | DELHI AIR | DUBAI | AIR |
| 15 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.0000 | $0.0000 | DELHI AIR | DUBAI | AIR |
| 16 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 12 | PCS | $0.027 | $0.320 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #7 — JPC GLOBAL · 3 shipments · $5.69 | |||||||||||
| 17 | Dec 2025 | TO THE, IMPORTING DEPARTMENT | Hong Kong | Suspension | 6 | PCS | $0.028 | $0.171 | MUMBAI AIR (SAHAR) | HONG KONG | AIR |
| 18 | Dec 2025 | TO THE, IMPORTING DEPARTMENT | Hong Kong | Suspension | 20 | PCS | $0.028 | $0.569 | MUMBAI AIR (SAHAR) | HONG KONG | AIR |
| 19 | Dec 2025 | TO THE, IMPORTING DEPARTMENT | Hong Kong | Suspension | 174 | PCS | $0.028 | $4.95 | MUMBAI AIR (SAHAR) | HONG KONG | AIR |
| SUPPLIER #8 — FALCON TRANSGLOBAL · 1 shipments · $2.02 | |||||||||||
| 20 | Nov 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 2 | NOS | $1.01 | $2.02 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #9 — IASO PHARMACEUTICALS PVT LTD · 2 shipments · $0.0000 | |||||||||||
| 21 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 8 | PCS | $0.0000 | $0.0000 | DELHI AIR | DUBAI | AIR |
| 22 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 8 | PCS | $0.0000 | $0.0000 | DELHI AIR | DUBAI | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
3 countries · 21 shipments · $906K · 5 Indian suppliers · 5 buyers
SHIPMENTS
21
USD
$906K
COUNTRIES
3
SUPPLIERS
5
BUYERS
5
HHI
8,985
concentrated
Top 3 destination countries in Europe
1
Greece (91.6%)
$830K
2
France (5.3%)
$48K
3
Germany (3.1%)
$28K
Top 5 Indian suppliers into Europe
1
LUPIN LTD
$858K
2
AJANTA PHARMA LTD
$32K
3
SAKAR HEALTHCARE LTD
$16K
4
GLOBAL PHARMA HEALTHCARE PVT LTD
$118.08
5
RICHMEL LIFE SCIENCES PVT LTD
$26.85
Top 4 Europe importers
1
ALKALOID AD SKOPJE · Greece
$830K
2
PLANET PHARMA SA · France
$48K
3
MERCKLE GMBHMERCKLE GMBH · Germany
$28K
4
DISTRIMEX · France
$26.85
Top 6 dosage forms
1
Tablet
$721K
2
Solution
$108K
3
Syrup
$50K
4
Suspension
$28K
5
Capsule
$118.08
6
Dispersible Tablet
$26.85
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $28K | $28K |
| Nov | 17 | $838K | $49K |
| Dec | 3 | $40K | $13K |
Shipment register · 21 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — LUPIN LTD · 16 shipments · $858K | |||||||||||
| 1 | Oct 2025 | MERCKLE GMBHMERCKLE GMBH | Germany | Suspension | 16.4K | NOS | $1.73 | $28K | NHAVA SHEVA SEA (JNPT) | Hamburg | SEA |
| 2 | Nov 2025 | ALKALOID AD SKOPJE | Greece | Tablet | 2.2K | NOS | $1.78 | $4K | NHAVA SHEVA SEA (JNPT) | Thessaloniki | SEA |
| 3 | Nov 2025 | ALKALOID AD SKOPJE | Greece | Tablet | 21.1K | NOS | $1.73 | $37K | NHAVA SHEVA SEA (JNPT) | Thessaloniki | SEA |
| 4 | Nov 2025 | ALKALOID AD SKOPJE | Greece | Tablet | 2.4K | NOS | $2.94 | $7K | NHAVA SHEVA SEA (JNPT) | Thessaloniki | SEA |
| 5 | Nov 2025 | ALKALOID AD SKOPJE | Greece | Tablet | 28.8K | NOS | $3.17 | $91K | NHAVA SHEVA SEA (JNPT) | Thessaloniki | SEA |
| 6 | Nov 2025 | ALKALOID AD SKOPJE | Greece | Tablet | 14.3K | NOS | $3.22 | $46K | NHAVA SHEVA SEA (JNPT) | Thessaloniki | SEA |
| 7 | Nov 2025 | ALKALOID AD SKOPJE | Greece | Tablet | 18.0K | NOS | $5.72 | $103K | NHAVA SHEVA SEA (JNPT) | Thessaloniki | SEA |
| 8 | Nov 2025 | ALKALOID AD SKOPJE | Greece | Solution | 16.2K | NOS | $3.09 | $50K | NHAVA SHEVA SEA (JNPT) | Thessaloniki | SEA |
| 9 | Nov 2025 | ALKALOID AD SKOPJE | Greece | Syrup | 16.2K | NOS | $3.08 | $50K | NHAVA SHEVA SEA (JNPT) | Thessaloniki | SEA |
| 10 | Nov 2025 | ALKALOID AD SKOPJE | Greece | Tablet | 42.8K | NOS | $3.16 | $135K | NHAVA SHEVA SEA (JNPT) | Thessaloniki | SEA |
| 11 | Nov 2025 | ALKALOID AD SKOPJE | Greece | Tablet | 7.2K | NOS | $5.70 | $41K | NHAVA SHEVA SEA (JNPT) | Thessaloniki | SEA |
| 12 | Nov 2025 | ALKALOID AD SKOPJE | Greece | Tablet | 3.6K | NOS | $5.65 | $20K | NHAVA SHEVA SEA (JNPT) | Thessaloniki | SEA |
| 13 | Nov 2025 | ALKALOID AD SKOPJE | Greece | Solution | 16.2K | NOS | $3.08 | $50K | NHAVA SHEVA SEA (JNPT) | Thessaloniki | SEA |
| 14 | Nov 2025 | ALKALOID AD SKOPJE | Greece | Tablet | 42.8K | NOS | $3.16 | $135K | NHAVA SHEVA SEA (JNPT) | Thessaloniki | SEA |
| 15 | Nov 2025 | ALKALOID AD SKOPJE | Greece | Tablet | 7.2K | NOS | $5.70 | $41K | NHAVA SHEVA SEA (JNPT) | Thessaloniki | SEA |
| 16 | Nov 2025 | ALKALOID AD SKOPJE | Greece | Tablet | 3.6K | NOS | $5.65 | $20K | NHAVA SHEVA SEA (JNPT) | Thessaloniki | SEA |
| SUPPLIER #2 — AJANTA PHARMA LTD · 2 shipments · $32K | |||||||||||
| 17 | Nov 2025 | PLANET PHARMA SA | France | Solution | 2.0K | NOS | $3.84 | $8K | MUMBAI AIR (SAHAR) | PARIS | AIR |
| 18 | Dec 2025 | PLANET PHARMA SA | France | Tablet | 6.1K | NOS | $3.97 | $24K | NHAVA SHEVA SEA (JNPT) | Le Havre | SEA |
| SUPPLIER #3 — SAKAR HEALTHCARE LTD · 1 shipments · $16K | |||||||||||
| 19 | Dec 2025 | PLANET PHARMA SA | France | Tablet | 15.0K | NOS | $1.08 | $16K | NHAVA SHEVA SEA (JNPT) | Rouen | SEA |
| SUPPLIER #4 — GLOBAL PHARMA HEALTHCARE PVT LTD · 1 shipments · $118.08 | |||||||||||
| 20 | Nov 2025 | UNLISTED BUYER | France | Capsule | 57 | NOS | $2.07 | $118.08 | CHENNAI SEA | Le Havre | SEA |
| SUPPLIER #5 — RICHMEL LIFE SCIENCES PVT LTD · 1 shipments · $26.85 | |||||||||||
| 21 | Dec 2025 | DISTRIMEX | France | Dispersible Tablet | 750 | PCS | $0.036 | $26.85 | DELHI AIR | PARIS - CHARLES DE G | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
2 countries · 10 shipments · $300K · 4 Indian suppliers · 4 buyers
SHIPMENTS
10
USD
$300K
COUNTRIES
2
SUPPLIERS
4
BUYERS
4
HHI
3,443
concentrated
Top 2 destination countries in Americas
1
United States (100.0%)
$300K
2
British Virgin Islands (0.0%)
$147.01
Top 4 Indian suppliers into Americas
1
ALKEM LABORATORIES LTD
$124K
2
FDC LTD
$97K
3
AUROBINDO PHARMA LTD
$79K
4
SARA TRADING CORP
$147.01
Top 4 Americas importers
1
ASCEND LABORATORIES LLC · United States
$124K
2
COVETRUS NORTH AMERICA LLC · United States
$97K
3
CRONUS PHARMA LLC · United States
$79K
4
VANTERPOOL ENTERPRISES LTD · British Virgin Islands
$147.01
Top 1 dosage forms
1
Tablet
$300K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $79K | $79K |
| Nov | 5 | $96K | $19K |
| Dec | 4 | $125K | $31K |
Shipment register · 10 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ALKEM LABORATORIES LTD · 1 shipments · $124K | |||||||||||
| 1 | Dec 2025 | ASCEND LABORATORIES LLC | United States | Tablet | 14.8K | NOS | $8.40 | $124K | NHAVA SHEVA SEA (JNPT) | Newark Apt/New York | SEA |
| SUPPLIER #2 — FDC LTD · 6 shipments · $97K | |||||||||||
| 2 | Nov 2025 | COVETRUS NORTH AMERICA LLC | United States | Tablet | 1.9K | NOS | $0.0000 | $0.0000 | DELHI AIR | CHICAGO O'HARE INT'L | AIR |
| 3 | Nov 2025 | COVETRUS NORTH AMERICA LLC | United States | Tablet | 4.0K | NOS | $8.73 | $35K | DELHI AIR | CHICAGO O'HARE INT'L | AIR |
| 4 | Nov 2025 | COVETRUS NORTH AMERICA LLC | United States | Tablet | 2.9K | NOS | $14.92 | $44K | DELHI AIR | CHICAGO O'HARE INT'L | AIR |
| 5 | Nov 2025 | COVETRUS NORTH AMERICA LLC | United States | Tablet | 1.9K | NOS | $8.73 | $17K | DELHI AIR | CHICAGO O'HARE INT'L | AIR |
| 6 | Dec 2025 | COVETRUS NORTH AMERICA LLC | United States | Tablet | 1.9K | NOS | $0.170 | $327.56 | DELHI AIR | CHICAGO O'HARE INT'L | AIR |
| 7 | Dec 2025 | COVETRUS NORTH AMERICA LLC | United States | Tablet | 4.0K | NOS | $0.170 | $679.79 | DELHI AIR | CHICAGO O'HARE INT'L | AIR |
| SUPPLIER #3 — AUROBINDO PHARMA LTD · 1 shipments · $79K | |||||||||||
| 8 | Oct 2025 | CRONUS PHARMA LLC | United States | Tablet | 248.8K | NOS | $0.319 | $79K | HYDERABAD ICD | CINCINNATI | ICD |
| SUPPLIER #4 — SARA TRADING CORP · 2 shipments · $147.01 | |||||||||||
| 9 | Nov 2025 | VANTERPOOL ENTERPRISES LTD | British Virgin Islands | Tablet | 30 | NOS | $3.48 | $104.40 | MUMBAI AIR (SAHAR) | TORTOLA | AIR |
| 10 | Dec 2025 | VANTERPOOL ENTERPRISES LTD | British Virgin Islands | Tablet | 20 | NOS | $2.13 | $42.61 | MUMBAI AIR (SAHAR) | TORTOLA | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 3 shipments · $44.73 · 1 Indian suppliers · 1 buyers
SHIPMENTS
3
USD
$44.73
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Oceania
1
Vanuatu (100.0%)
$44.73
Top 1 Indian suppliers into Oceania
1
BRINTON PHARMACEUTICALS LTD
$44.73
Top 0 Oceania importers
Top 1 dosage forms
1
Tablet
$44.73
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 0 | $0.0000 | — |
| Dec | 3 | $44.73 | $14.91 |
Shipment register · 3 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — BRINTON PHARMACEUTICALS LTD · 3 shipments · $44.73 | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Vanuatu | Tablet | 10 | NOS | $2.22 | $22.25 | MUMBAI AIR (SAHAR) | PORT VILA | AIR |
| 2 | Dec 2025 | UNLISTED BUYER | Vanuatu | Tablet | 10 | NOS | $0.025 | $0.248 | MUMBAI AIR (SAHAR) | PORT VILA | AIR |
| 3 | Dec 2025 | UNLISTED BUYER | Vanuatu | Tablet | 10 | NOS | $2.22 | $22.24 | MUMBAI AIR (SAHAR) | PORT VILA | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 35 Indian cefpodoxime exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped cefpodoxime in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | LUPIN LTD | MUMBAI | 17 | $893K | Suspension, Tablet, Solution | Africa, Europe |
| 2 | AUROBINDO PHARMA LTD | PATANCHERU (M) | 3 | $144K | Tablet, Suspension | Americas, Africa |
| 3 | ALKEM LABORATORIES LTD | Panvel | 2 | $132K | Tablet | Africa, Americas |
| 4 | TWENTYFIRST CENTURY PHARMACEUTICALS PRIVATE LIMITE | IQBALPUR RD. | 4 | $108K | Tablet | Africa |
| 5 | FDC LTD | MUMBAI | 6 | $97K | Tablet | Americas |
| 6 | INNOVA CAPTAB LTD | BADDI | 6 | $90K | Suspension, Tablet | Africa |
| 7 | UNOSOURCE PHARMA LTD | MUMBAI | 5 | $49K | Tablet | Asia |
| 8 | SAKAR HEALTHCARE LTD | AHMEDABAD | 2 | $33K | Tablet | Africa, Europe |
| 9 | AJANTA PHARMA LTD | MUMBAI | 2 | $32K | Solution, Tablet | Europe |
| 10 | BHARAT PARENTERALS LTD | DIST.VADODARA | 1 | $25K | Tablet | Africa |
| 11 | THEON PHARMACEUTICALS LTD | THEON PHARMACEUTICALS LIMITED | 2 | $12K | Tablet | Asia |
| 12 | AQUAREN HEALTHCARE PVT LTD | AHMEDABAD | 2 | $10K | Dry Syrup | Africa |
| 13 | SANCE LABORATORIES PVT LTD | KOTTAYAM | 1 | $9K | Suspension | Africa |
| 14 | ZEST PHARMA | INDORE | 2 | $8K | Tablet, Syrup | Africa |
| 15 | MAXIM PHARMACEUTICALS PVT LTD | PUNE | 1 | $8K | Tablet | Asia |
| 16 | S PHARMA | DELHI | 2 | $6K | Tablet | Asia |
| 17 | KLV HEALTHCARE PVT LTD | DAHISAR | 9 | $6K | Tablet | Africa |
| 18 | MILTON GLOBEXO LLP | MUMBAI | 2 | $5K | Pack | Africa |
| 19 | AFRO LIFESCIENCE | MUMBAI | 1 | $4K | Tablet | Africa |
| 20 | BAKER & DAVIS PVT LTD | MUMBAI | 4 | $4K | Tablet | Africa |
| 21 | AURA PHARMACEUTICALS PVT LTD | MUMBAI M S | 1 | $4K | Dispersible Tablet | Africa |
| 22 | AKASH PHARMA EXPORTS | PALAKKAD | 1 | $2K | Syrup | Africa |
| 23 | ARISTO PHARMACEUTICALS PVT LTD | MUMBAI | 1 | $1K | Dry Syrup | Africa |
| 24 | TRAILBLAZERS PHARMACEUTICALS | Bhiwandi | 1 | $413.31 | Suspension | Africa |
| 25 | SANITAS MEDTECH INSTITUTE PVT LTD | Narhen | 2 | $251.93 | Tablet | Asia |
| 26 | SARA TRADING CORP | JABALPUR | 2 | $147.01 | Tablet | Americas |
| 27 | GLOBAL PHARMA HEALTHCARE PVT LTD | KANCHIPURAM THIRUPORUR | 1 | $118.08 | Capsule | Europe |
| 28 | DERRIC WOOD | SUBHASH PLACE | 4 | $112.45 | Tablet | Asia |
| 29 | BRINTON PHARMACEUTICALS LTD | PUNE | 3 | $44.73 | Tablet | Oceania |
| 30 | SAINTROY LIFESCIENCE LLP | Surat | 1 | $40.18 | Suspension | Africa |
| 31 | RICHMEL LIFE SCIENCES PVT LTD | DELHI | 1 | $26.85 | Dispersible Tablet | Europe |
| 32 | CURE EARTH PHARMA | Chennai | 1 | $24.48 | Suspension | Africa |
| 33 | JPC GLOBAL | MUMBAI | 3 | $5.69 | Suspension | Asia |
| 34 | FALCON TRANSGLOBAL | NAGPUR | 1 | $2.02 | Tablet | Asia |
| 35 | IASO PHARMACEUTICALS PVT LTD | NEW DELHI | 2 | $0.0000 | Tablet | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 34 global cefpodoxime importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian cefpodoxime in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | ALKALOID AD SKOPJE | Greece | 15 | $830K | LUPIN LTD | Tablet, Solution, Syrup |
| 2 | ASCEND LABORATORIES LLC | United States | 1 | $124K | ALKEM LABORATORIES LTD | Tablet |
| 3 | COVETRUS NORTH AMERICA LLC | United States | 6 | $97K | FDC LTD | Tablet |
| 4 | ELWALIEF INTERNATIONAL FOR MULTI | Sudan | 4 | $81K | INNOVA CAPTAB LTD | Tablet |
| 5 | CRONUS PHARMA LLC | United States | 1 | $79K | AUROBINDO PHARMA LTD | Tablet |
| 6 | AUROGEN SOUTH AFRICA (PTY) LTD | South Africa | 2 | $65K | AUROBINDO PHARMA LTD | Suspension |
| 7 | MARCSON HEALTHCARE LTD | Nigeria | 2 | $54K | TWENTYFIRST CENTURY … | Tablet |
| 8 | ALLEGENS COMPANY LTD | Vietnam | 5 | $49K | UNOSOURCE PHARMA LTD | Tablet |
| 9 | PLANET PHARMA SA | France | 3 | $48K | AJANTA PHARMA LTD | Solution, Tablet |
| 10 | UPD LEA GLEN, PHARMA DYNAMICS | South Africa | 1 | $34K | LUPIN LTD | Suspension |
| 11 | MERCKLE GMBHMERCKLE GMBH | Germany | 1 | $28K | LUPIN LTD | Suspension |
| 12 | STE PRINCE PHARMA SARL | DR Congo | 3 | $25K | SAKAR HEALTHCARE LTD | Tablet, Suspension |
| 13 | M/S.CHANRAIHEALTH CARE LTD | Nigeria | 1 | $25K | BHARAT PARENTERALS LTD | Tablet |
| 14 | EURO PHARMA LTD | Kenya | 2 | $10K | AQUAREN HEALTHCARE P… | Dry Syrup |
| 15 | KADA FOR MULTI ACTIVITIES CO.LTDELI | Sudan | 1 | $9K | SANCE LABORATORIES P… | Suspension |
| 16 | SYNER-MED PHARMACEUTICALS (KENYA) L | Kenya | 2 | $8K | ZEST PHARMA | Tablet, Syrup |
| 17 | THAIAN MEDICAL IMPORT -EXPORT JOINT | Vietnam | 1 | $8K | MAXIM PHARMACEUTICAL… | Tablet |
| 18 | ASCEND LABORATORIES (PTY) LTD | South Africa | 1 | $7K | ALKEM LABORATORIES LTD | Tablet |
| 19 | TRUST ANESTHETIC LTD | Afghanistan | 2 | $6K | S PHARMA | Tablet |
| 20 | KUOL UTONG MIYEN | Sudan | 2 | $5K | MILTON GLOBEXO LLP | Pack |
| 21 | CYERDITTRADING CO LTD | Kenya | 1 | $4K | AFRO LIFESCIENCE | Tablet |
| 22 | TO,THE ORDER R.D. CONGO, THE | DR Congo | 1 | $4K | AURA PHARMACEUTICALS… | Dispersible Tablet |
| 23 | ADIL HISSEIN ISMAIL | Chad | 1 | $3K | BAKER & DAVIS PVT LTD | Tablet |
| 24 | AMDJERAS FIELD HOSPITAL | Chad | 1 | $2K | AKASH PHARMA EXPORTS | Syrup |
| 25 | QUEEENS ENTERPRISES CO LTD | Sudan | 3 | $2K | BAKER & DAVIS PVT LTD | Tablet |
| 26 | TRIDEM PHARMA KENYA LTD | Kenya | 1 | $1K | ARISTO PHARMACEUTICA… | Dry Syrup |
| 27 | AMRA PHARMACEUTICALS | Somalia | 1 | $413.31 | TRAILBLAZERS PHARMAC… | Suspension |
| 28 | SUCCESS INTER LINK PTE LTD | Singapore | 2 | $251.93 | SANITAS MEDTECH INST… | Tablet |
| 29 | VANTERPOOL ENTERPRISES LTD | British Virgin Islands | 2 | $147.01 | SARA TRADING CORP | Tablet |
| 30 | EMIRATES POST COMPANY | United Arab Emirates | 6 | $112.45 | DERRIC WOOD | Tablet |
| 31 | DISTRIMEX | France | 1 | $26.85 | RICHMEL LIFE SCIENCE… | Dispersible Tablet |
| 32 | KALKAAL HOSPITAL | Somalia | 1 | $24.48 | CURE EARTH PHARMA | Suspension |
| 33 | TO THE, IMPORTING DEPARTMENT | Hong Kong | 3 | $5.69 | JPC GLOBAL | Suspension |
| 34 | EMIRATES POST GROUP | United Arab Emirates | 1 | $2.02 | FALCON TRANSGLOBAL | Tablet |
This report covers 99 2025-Q4 Cefpodoxime shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/cefpodoxime
Talk to our trade analyst
Need a custom cefpodoxime report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/cefpodoxime
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Cefpodoxime product page
Live data, supplier directory, price trends, and trade route analysis